Squarepoint Ops »

Enliven Therapeutics shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2025-09-30 $734k 36k 20.47

More positions owned by Squarepoint Ops

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Apple (AAPL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Ishares Tr Msci Emg Mkt Etf (EEM)
Advanced Micro Devices (AMD)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Palantir Technologies Cl A (PLTR)
Netflix (NFLX)

View all positions for Squarepoint Ops

Top funds holding Enliven Therapeutics

OrbiMed Advisors
FMR
Commodore Capital
Fairmount Funds Management
BlackRock
VR Adviser
Polar Capital Holdings
Vanguard Group
Henderson Group
Novo A/S
Pictet Asset Management Holding SA
Blackstone Group
Capital Research Global Investors
Citadel Advisors
Vestal Point Capital

View all funds holding Enliven Therapeutics